1. Europe Pubmed Central (2011). Performance Evaluation of VITEK 2 System in Meropenem Susceptibility Testing of Clinical Pseudomonas aeruginosa Isolates. Turkey: Yeditepe University Faculty of Medicine, Department of Medical Microbiology, 45(3), 411-421. Recuperado de http://www.europepmc/abstract/med/21935774
2. Ayestarán, X., Molina, A., Oliver, O., Delgado, F. (2010). Revisión de Carbapenems. Informe para la Comisión de Infección Hospitalaria del Hospital Universitario Son Dureta. Palma de Mallorca, Islas Baleares, España.
3. Clarkson, M., Friedewald, J., Eustace, J., Rabb, H. (2008). Acute kidney injury. In: Brenner BM, Brenner and Rector’s (Ed), The Kidney. (8th ed. Philadelphia, Chap. 29). Nederland: Saunders Elsevier. https://doi.org/10.1038/ki.2008.117
4. Comité de Expertos en la Selección y Uso de Medicamentos Esenciales, (2008). Second Meeting of the Subcommittee of the Expert Committee on the Selection and Use of Essential Medicines. (29 September to 3 October 2008). Geneva, Switzerland.
5. Curcio, D. y Alí, A. y Duarte, A. (2009). Prescription of antibiotics in intensive care units in Latin America: an observational study. Journal of Chemotherapy. 21(5), 527-534. https://doi.org/10.1179/joc.2009.21.5.527